Preferred Label : glasdegib;

CISMeF synonym : 1-(2-(1H-benzo(d)imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea;

UNII : K673DMO5H9;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/daurismo-5332.html
2020
false
false
false
Canada
French
drug evaluation
Glasdegib
Glasdegib Maleate
glasdegib
glasdegib
benzimidazoles
phenylurea compounds

---
https://www.ema.europa.eu/en/medicines/human/EPAR/daurismo
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Glasdegib
Glasdegib
benzimidazoles
benzimidazoles
phenylurea compounds
phenylurea compounds
glasdegib
antineoplastic agents
antineoplastic agents
adult
aged
antineoplastic combined chemotherapy protocols
cytarabine
leukemia, myeloid, acute
orphan drug production
administration, oral
SMO protein, human
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Glasdegib Maleate
Glasdegib Maleate
glasdegib
glasdegib
Smoothened Receptor
receptors, g-protein-coupled

---
Nous contacter.
26/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.